Medopad

By Kevin Roche November 15, 2019 Headlines

Medopad, which does something related to gathering health information from wearables, pads its bank account with $25 in new capital, apparently raised at a valuation of around $200 million. There is too much capital and when there is, it does stupid stuff.

https://techcrunch.com/2019/11/05/medopad-raises-25m-led-by-bayer-to-develop-biomarkers-tracked-via-apps-and-wearables/

Author Kevin Roche

The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry through Roche Consulting, LLC. Mr. Roche is available to assist health care companies through consulting arrangements and may be reached at khroche@healthy-skeptic.com.

More posts by Kevin Roche

Leave a Reply Cancel reply

© 2019 Healthy Skeptic.